Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

Article  PubMed  Google Scholar 

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108

Article  PubMed  Google Scholar 

Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353(23):2477–2490

Article  PubMed  Google Scholar 

Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373(9669):1119–1132

Article  PubMed  Google Scholar 

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A et al (2012) Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJU Int 110(1):76–83

Article  PubMed  Google Scholar 

Casuscelli J, Becerra MF, Seier K, Manley BJ, Benfante N, Redzematovic A, Stief CG, Hsieh JJ, Tickoo SK, Reuter VE et al (2019) Chromophobe Renal Cell Carcinoma: results from a large single-Institution Series. Clin Genitourin Cancer 17(5):373–379e374

Article  PubMed  PubMed Central  Google Scholar 

Garje R, Elhag D, Yasin HA, Acharya L, Vaena D, Dahmoush L (2021) Comprehensive review of chromophobe renal cell carcinoma. Crit Rev Oncol Hematol 160:103287

Article  PubMed  Google Scholar 

Gudbjartsson T, Thoroddsen A, Petursdottir V, Hardarson S, Magnusson J, Einarsson GV (2005) Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology 66(6):1186–1191

Article  PubMed  Google Scholar 

Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ et al (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37(10):1490–1504

Article  PubMed  Google Scholar 

Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN, Jordan TW (2007) Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 31(6):957–960

Article  PubMed  Google Scholar 

Kuthi L, Jenei A, Hajdu A, Nemeth I, Varga Z, Bajory Z, Pajor L, Ivanyi B (2017) Prognostic factors for renal cell carcinoma subtypes diagnosed according to the 2016 WHO renal tumor classification: a study involving 928 patients. Pathol Oncol Res 23(3):689–698

Article  PubMed  Google Scholar 

Paner GP, Amin MB, Alvarado-Cabrero I, Young AN, Stricker HJ, Moch H, Lyles RH (2010) A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Am J Surg Pathol 34(9):1233–1240

Article  PubMed  Google Scholar 

Avulova S, Cheville JC, Lohse CM, Gupta S, Potretzke TA, Tsivian M, Thompson RH, Boorjian SA, Leibovich BC, Potretzke AM (2021) Grading Chromophobe Renal Cell Carcinoma: evidence for a four-tiered classification incorporating Coagulative Tumor Necrosis. Eur Urol 79(2):225–231

Article  PubMed  Google Scholar 

Ohashi R, Martignoni G, Hartmann A, Calio A, Segala D, Stohr C, Wach S, Erlmeier F, Weichert W, Autenrieth M et al (2020) Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme. Virchows Arch 476(3):409–418

Article  PubMed  Google Scholar 

Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP (2018) Predicting Oncologic outcomes in Renal Cell Carcinoma after surgery. Eur Urol 73(5):772–780

Article  PubMed  Google Scholar 

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401–404

Article  PubMed  Google Scholar 

Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV et al (2018) An Integrated TCGA Pan-cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173(2):400–416 e411

Article  PubMed  PubMed Central  Google Scholar 

Lopez-Beltran A, Montironi R, Cimadamore A, Cheng L (2021) Grading of Chromophobe Renal Cell Carcinoma: do we need it? Eur Urol 79(2):232–233

Article  PubMed  Google Scholar 

Steffens S, Janssen M, Roos FC, Becker F, Steinestel J, Abbas M, Steinestel K, Wegener G, Siemer S, Thuroff JW et al (2014) The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma. Hum Pathol 45(12):2411–2416

Article  PubMed  Google Scholar 

Moch H, Ohashi R (2021) Chromophobe renal cell carcinoma: current and controversial issues. Pathology 53(1):101–108

Article  PubMed  Google Scholar 

Montironi R, Cimadamore A, Ohashi R, Cheng L, Scarpelli M, Lopez-Beltran A, Moch H (2021) Chromophobe Renal Cell Carcinoma aggressiveness and Immuno-Oncology Therapy: how to distinguish the good one from the bad one. Eur Urol Oncol 4(2):331–333

Article  PubMed  Google Scholar 

Rogala J, Kojima F, Alaghehbandan R, Ptakova N, Bravc A, Bulimbasic S, Perez Montiel D, Slisarenko M, Ali L, Kuthi L et al (2022) Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic and molecular-genetic analysis of 10 cases. Bosn J Basic Med Sci 22(4):531–539

PubMed  PubMed Central  Google Scholar 

Browning L, Colling R, Verrill C (2021) WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade. Diagn Pathol 16(1):75

Article  PubMed  PubMed Central  Google Scholar